Oil prices hold sharp losses with focus on secondary India tariffs
Investing.com -- The Cigna (NYSE:CI) Group reported better-than-expected second quarter 2025 results on Wednesday, as strong growth in its Evernorth Health Services segment drove revenue significantly higher. Shares rose 1% following the announcement.
The health services company posted adjusted earnings of $7.20 per share, exceeding analyst expectations of $7.16. Revenue surged 11% YoY to $67.2 billion, well above the consensus estimate of $62.66 billion. The company reaffirmed its full-year 2025 adjusted earnings outlook of at least $29.60 per share, slightly below analyst projections of $29.69.
Evernorth Health Services, which includes pharmacy benefit management and specialty pharmacy services, was the primary growth driver with adjusted revenues increasing 17% to $57.8 billion compared to the same period last year. The segment’s pre-tax adjusted income rose 5% to $1.7 billion.
"Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients enables us to deliver meaningful value," said David M. Cordani, chairman and CEO of The Cigna Group. "Our performance in the second quarter reflects our disciplined execution and the strength of our business mix."
The Cigna Healthcare segment saw adjusted revenues decrease 18% to $10.8 billion, primarily due to the divestiture of its Medicare businesses to Health Care Services Corporation in March 2025. Excluding this transaction, the segment’s revenue would have increased 7% YoY.
The company’s medical care ratio rose to 83.2% from 82.3% in the year-ago quarter, reflecting expected higher stop loss medical costs.
Total (EPA:TTEF) pharmacy customers increased 3% from December 31, 2024, to 121.9 million, while total medical customers decreased 6% to 18 million, primarily due to the HCSC transaction.